Syndax Pharmaceuticals, Inc. (SNDX) NASDAQ
18.39
-0.46(-2.44%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
18.39
-0.46(-2.44%)
Currency In USD
| Market Cap | 1.82B |
| Enterprise Value | 2.03B |
| P/E Ratio | -6.55 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 7.5 |
| Price/Book Ratio | 38.27 |
| Enterprise/Revenue | 8.49 |
| Enterprise/EBITDA | -11.34 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.12 |
| Operating Margin | -1.03 |
| Return On Assets | -0.51 |
| Return On Equity | -2.57 |
| Revenue | 172.35M |
| Revenue/Share | 2.51 |
| Gross Profit | 165.38M |
| EBITDA | -251.63M |
| Net Income | -285.42M |
| Diluted EPS | -3.29 |
| Total Cash | 352.06M |
| Total Cash/Share | 4.06 |
| Total Debt | 345.36M |
| Total Debt/Equity | 8.3 |
| Current Ratio | 5.47 |
| Book Value Per Share | 0.48 |
| 52-Week Change | 67.49 |
| 52-Week High | 25.59 |
| 52-Week Low | 8.59 |
| Moving Average 50 Days | 21.9 |
| Moving Average 200 Days | 19.37 |
| Average Volume | 1.55M |
| Shares Outstanding | 88.61M |
| % Held by Institutions | 114.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |